Barbara Cortelazzi

Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma

Sabrina Pricl, Barbara Cortelazzi, Valentina Dal Col et al. · Molecular Oncology · 2014 · 158 citations · Full text

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)

Laura D. Locati, Federica Perrone, Marco Losa et al. · Oral Oncology · 2009 · 158 citations

Medicine, Immunology, Pathology +7

<i>TP53</i> Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma

Federica Perrone, Paolo Bossi, Barbara Cortelazzi et al. · Journal of Clinical Oncology · 2010 · 149 citations · Full text

Tumor Biology, Surgical Oncology, Pathologic Complete Response +15

Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers

Laura D. Locati, Federica Perrone, Barbara Cortelazzi et al. · Head & Neck · 2014 · 126 citations

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Roberta Granata, Rosalba Miceli, Ester Orlandi et al. · Annals of Oncology · 2011 · 106 citations · Full text

Oncology, Smoking Status, Epidemiology Of Cancer +7